| Regulatory role of sphingomyelin metabolites in hypoxia-induced vascular smooth muscle cell proliferation. | |
| | |
MedLine Citation:
|
PMID: 12485605 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Vascular cell adaptive response to hypoxic stress includes enhanced production of sphingomyelin metabolites that regulate cell growth. Here, we examined the vascular smooth muscle (VSM) cell adaptive response to hypoxia (2 and 5% O(2)) and demonstrated that acute (</=16h) hypoxic stress significantly stimulated VSM cell growth compared to cells grown under normoxic (21% O(2)) conditions. This stimulatory effect of hypoxia on VSM cell growth was significantly inhibited by pretreatment of cells with D-erythro-N,N-dimethylsphingosine, an inhibitor of sphingosine kinase. These results suggest a mechanism by which sphingosine 1-phosphate (S-1-P), a promitogenic sphingolipid-derived second messenger, may play a key role in hypoxia-induced VSM cell growth. Supporting this, S-1-P formation was significantly increased in VSM cells subjected to hypoxia. The hypoxia-induced increase in S-1-P level correlated with the decrease in total cellular ceramide content, a sphingolipid metabolite associated with inhibition of cell growth. The activity of sphingomyelinase was also significantly inhibited in hypoxia-treated VSM cells, likely further contributing to a decrease in total intracellular content of ceramide. As a decrease in ceramide content may play a role in hypoxia-induced VSM growth, we next examined the effects of ceramide in VSM cell growth. Elevating intracellular ceramide content through exogenous (C(6)-ceramide) or endogenous (ceramidase inhibition) manipulations led to a decrease in hypoxia-induced VSM cell growth. In contrast, hypoxia-induced VSM cell growth was further enhanced by S-1-P treatment. Together, our study indicates that hypoxia-induced VSM cell growth may be modulated by sphingomyelin metabolism that results in reduction of total intracellular ceramide level with concomitant increase in S-1-P formation. |
| | |
Authors:
|
Jong K Yun; Mark Kester |
Related Documents
:
|
346585 - Ergosterol biosynthesis in yeast. pathways in the late stages and their variation under... 3421495 - Effects of nonvolatile agents on oxygen demand and energy status in isolated hepatocytes. 2353135 - Hypoxia/reoxygenation injury in liver: kupffer cells are much more vulnerable to reoxyg... 12106105 - Effects of putative neurotransmitters of the carotid body on its own glomus cells. 6592605 - Autoradiographic assay of mutants resistant to diphtheria toxin in mammalian cells in v... 19129235 - A role for monoubiquitinated fancd2 at telomeres in alt cells. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. |
Journal Detail:
|
Title: Archives of biochemistry and biophysics Volume: 408 ISSN: 0003-9861 ISO Abbreviation: Arch. Biochem. Biophys. Publication Date: 2002 Dec |
Date Detail:
|
Created Date: 2002-12-17 Completed Date: 2003-01-24 Revised Date: 2007-11-14 |
Medline Journal Info:
|
Nlm Unique ID: 0372430 Medline TA: Arch Biochem Biophys Country: United States |
Other Details:
|
Languages: eng Pagination: 78-86 Citation Subset: IM |
Affiliation:
|
Department of Pharmacology, Penn State College of Medicine, Hershey, PA 17033, USA. jky1@psu.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Aorta Cell Division / physiology* Cell Hypoxia / physiology* Cells, Cultured Ceramides / metabolism Lysophospholipids* Muscle, Smooth, Vascular / cytology* Rats Sphingomyelin Phosphodiesterase / metabolism Sphingomyelins / metabolism* Sphingosine / analogs & derivatives*, metabolism Thymidine / metabolism Tritium |
| Grant Support | |
ID/Acronym/Agency:
|
CA91155/CA/NCI NIH HHS; DK 53715/DK/NIDDK NIH HHS; HL 66371/HL/NHLBI NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Ceramides; 0/Lysophospholipids; 0/Sphingomyelins; 10028-17-8/Tritium; 123-78-4/Sphingosine; 26993-30-6/sphingosine 1-phosphate; 50-89-5/Thymidine; EC 3.1.4.12/Sphingomyelin Phosphodiesterase |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Chronic liver and renal diseases differently affect structure of human serum albumin.
Next Document: A novel prothrombin activator from the venom of Micropechis ikaheka: isolation and characterization.